Press Release Details
Twist Bioscience Launches Enzymatic Fragmentation Library Preparation Kit for High Uniformity, High-Yield Amplification, Streamlined Next Generation Sequencing Workflow for Targeted Applications
-- Efficient Library Preparation Prevents Wasted Samples --
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210525005242/en/

Twist Library Preparation Enzymatic Fragmentation Kit 2.0, a robust all-in-one solution designed to maximize accuracy and efficiency in library construction and amplification when conducting next-generation sequencing (NGS) for targeted applications. (Photo: Business Wire)
“Utilizing robust sample preparation technologies to generate sequencing libraries sets the stage for high-quality data and accurate results,” said Emily M. Leproust, Ph.D., CEO and co-founder of
The Library Preparation Enzymatic Fragmentation Kit 2.0 builds on Twist’s existing Library Preparation portfolio, giving customers more options when selecting a solution that works for their unique application or sample type. Combined with Twist’s industry-leading target enrichment panels that provide exceptional capture uniformity to avoid over-sequencing of areas outside the desired target regions, this new kit integrates a new amplification mix specifically developed for NGS applications.
“Twist continues to add innovative solutions to its expanding NGS portfolio to support researchers in a variety of disciplines. The introduction of these new tools showcases our ongoing commitment to the research and clinical communities, as we help them get to answers faster, deliver better outcomes and drive research forward,” continued Dr. Leproust.
About the Twist Library Preparation Enzymatic Fragmentation Kit 2.0
The Twist Library Preparation Enzymatic Fragmentation (EF) Kit 2.0 is a customized workflow to efficiently prepare samples that generate more accurate NGS results. The EF Kit 2.0 enables a streamlined workflow that combines library preparation steps into a single-tube reaction which, alongside a low chimera rate and Twist’s highly uniform target enrichment workflow, translates into high quality library preparation and NGS data.
About
Follow us on Twitter | Facebook | LinkedIn | YouTube
Legal Notice Regarding Forward-Looking Statements
This press release contains forward-looking statements. All statements other than statements of historical facts contained herein, including but not limited to the ability of the Twist Library Preparation Enzymatic Fragmentation Kit 2.0 to enable Twist customers pursuing liquid biopsy, rare variants and other critical research to generate high-quality data consistently, to obtain answers faster, to deliver better outcomes and to drive research forward, are forward-looking statements reflecting the current beliefs and expectations of management made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties, and other important factors that may cause Twist Bioscience’s actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements. Such risks and uncertainties include, among others, the risks and uncertainties of the ability to attract new customers and retain and grow sales from existing customers; risks and uncertainties of rapidly changing technologies and extensive competition in synthetic biology could make the products
View source version on businesswire.com: https://www.businesswire.com/news/home/20210525005242/en/
925- 202-6211
abitting@twistbioscience.com
Source: